Stock listing

A2H8SU Stock Price, News, Filings & Events — Advicenne Sa

Selected listing: A2H8SU · LSX · EUR · DE

The selected listing A2H8SU:LSX represents Advicenne Sa, a biopharmaceutical company focused on developing innovative treatments for rare kidney diseases. Recently, the company has been active in advancing its clinical trials and has made updates regarding its regulatory filings. Investors can stay informed about upcoming events and announcements that may impact the company's market position. Advicenne Sa continues to navigate the evolving landscape of the healthcare sector while aiming to address unmet medical needs.

A2H8SU:LSXEURDEUpdated July 21, 2026
Advicenne Sa logo
Ticker
A2H8SU:LSX
Asset type
Stock
Market cap
$27.0M
Sector
Health Technology
Industry
Pharmaceuticals: Generic
Exchange
LSX
Currency
EUR

Advicenne Sa A2H8SU:LSX stock context

The selected listing A2H8SU:LSX represents Advicenne Sa, a biopharmaceutical company focused on developing innovative treatments for rare kidney diseases. Recently, the company has been active in advancing its clinical trials and has made updates regarding its regulatory filings. Investors can stay informed about upcoming events and announcements that may impact the company's market position. Advicenne Sa continues to navigate the evolving landscape of the healthcare sector while aiming to address unmet medical needs.

Research Advicenne Sa

Alternate listings